oop PsA Cross-sectional observational study evaluating clinical specialty setting as determinant of management of patients with psoriatic arthritis
Not Applicable
- Conditions
- Psoriatic arthritis
- Registration Number
- JPRN-UMIN000023510
- Lead Sponsor
- Abbvie GK
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 1200
Inclusion Criteria
?Diagnosed with suspected or established PsA
?Female or male
?Age of 18 years or older
?Signed a patient authorization form to use and disclose personal health information (or informed consent, where applicable)
?Able to read and understand patients questionnaires in provided language
Exclusion Criteria
No formal Exclusion criteria exist
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ?Time from inflammatory musculoskeletal symptom onset to PsA diagnosis<br>?Time from PsA diagnosis to first csDMARD<br>?Time from PsA diagnosis to first bDMARD<br>?Time from first csDMARD to first bDMARD
- Secondary Outcome Measures
Name Time Method PsA disease activity<br>?Joint disease activity (TJC/SJC, enthesitis count and dactylitis count, axial involvement by ASDAS)<br>?Skin disease activity (PGA, BSA, psoriatic nails count)<br><br>Disease burden<br>?Physical function (HAQ-DI score)<br>?Quality of life (SF12v2.0 score)<br>?Work productivity (WPAI scores)<br>?DLQI score